Hyperbaric Oxygen Therapy (HBOT) Devices Market – Insights
Hyperbaric oxygen therapy (HBOT) devices deliver 100% pure oxygen to tissues in the body under high atmospheric pressure. The pressure is increased to three times the normal atmospheric pressure during HBOT. This in turn leads to high amount of partial pressure of oxygen. One atmosphere absolute are subjected to be around 14.7 pounds per square inch of pressure under normal conditions. Breathable air contains 21% oxygen and 79% nitrogen. Inhaling 100% oxygen may lead to increase in atmospheric pressure of the body. The oxygen molecules become condensed. This enables to breathe a higher amount of partial pressure oxygen, which dissolves in the plasma around 10 to 15 times greater than normal. This can be termed as super-saturation of oxygen in the tissues, which leads to increasing capillary growth, increase in white blood cell (WBC) activity, new tissues development, increase in oxygen tension in hypoxic areas, reduction in the size of gas bubbles, and various other physiological effects.
HBOT devices aid in the treatment of several diseases such as asthma, HIV/AIDS, Bell’s palsy, Parkinson’s disease, spinal cord injuries, hepatitis, migraines, multiple sclerosis, stroke, and sport injuries. HBOT devices are Food and Drug Administration (FDA) approved for the treatment of decompression sickness, thermal, necrotizing soft tissues infection, and burn injury. These devices can also used in the off-label (means the medication is not specified in the FDA’s approved packaging label) medical induction treatment such as brain injuries and cancer. Such wide range of applications of HBOT devices is expected to boost growth of the HBOT devices market.
A sample of this report is available upon request @ https://www.coherentmarketinsights.com/insight/request-sample/553
Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, by Product Type (Monoplace HBOT Devices, Multiplace HBOT Devices, and Topical HBOT Devices), By Application (Wound Healing, Decompression Sickness, Infection, Gas Embolism, and Others), By End User (Hospital & Clinics, Ambulatory Surgery Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 2255.3 million in 2018, and is expected to exhibit a CAGR of 6.6% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.
Rising number of diabetic foot ulcers is expected to drive demand for hyperbaric oxygen therapy devices which is expected to augment the market growth over the forecast period. For instance, according to the National Center for Biotechnology Information, in 2015, the incidence of diabetic foot ulcers (DFU) ranged from 4% to 10% among hospitalized patients in China.
Increasing expansion strategies by market players is expected to drive the market growth over the forecast period. For instance, in May 2017, AHA Hyperbarics GmbH, announced the launch of its subsidiary AHA Hyperbarics Australia Pty Ltd, in Australia, in order to expand the company’s business and product offerings.
Browse 38 Market Data Tables and 26 Figures spread through 173 Pages and in-depth TOC on ‘Hyperbaric Oxygen Therapy Devices Market’- Global Forecast to 2027, Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, by Product Type (Monoplace HBOT Devices, Multiplace HBOT Devices, Topical HBOT Devices), by Application (Wound Healing, Decompression Sickness, Infection, Gas Embolism and Others), by End User (Hospital & Clinics, Ambulatory Surgery Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), To know the latest trends and insights prevalent in the Hyperbaric Oxygen Therapy Devices market Press Release, click the link below: https://www.coherentmarketinsights.com/press-release/hyperbaric-oxygen-therapy-devices-market-2784
North America is expected to hold a dominant position in the hyperbaric oxygen therapy devices market over the forecast period, owing to rising number of diabetic foot ulcers and non-healing wounds in the region. For instance, according to Centers for Disease Control & Prevention (CDC), in 2016, 23.6 million people suffered from diabetes, which is 7.8% of the total population in the U.S. One third of the diabetic population in the U.S also suffered from lower extremity wounds.
Markets in Africa and Middle East are expected to witness growth in the hyperbaric oxygen therapy devices market over the forecast period due to increasing strategic partnerships by market players in the region to enhance their market presence. For instance, in June 2018, Sechrist Industries, Inc. announced the partnership with Dartmouth College’s Geisel School of Medicine to bring Hyperbaric Oxygen Therapy (HBOT) in Tanzania, East Africa. The therapy will be used for treatment of chronic bone infections, severe anemia, non-healing hypoxic wounds and other conditions. Also, market players are enhancing their market presence by opening new centers in the region. For instance, in September 2019, BioBarica, announced the launch of Buenos Aires, Argentina, in order to offer the hyperbaric oxygen therapy in the Argentina region.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/553
Key Takeaways of the Hyperbaric Oxygen Therapy Devices Market:
- The global hyperbaric oxygen therapy devices market is expected to exhibit a CAGR of 6.6% over the forecast period, owing to expansion strategies adopted by market players. For instance, in December 2019, BioBarica announced the launch of a new center located at Sevilla, Spain, for offering hyperbaric oxygen therapy in the Europe.
- Key players operating in the global hyperbaric oxygen therapy devices market are Fink Engineering Pty Ltd., Gulf Coast Hyperbarics, Inc., SOS Medical Group Ltd., IHC Hytech B.V., ETC BioMedical Systems, Haux-Life-Support GmbH, Sechrist Industries, Inc., GWR Medical, Inc., Hyperbaric Modular Systems, Inc., Hearmec Co., Ltd., and Premier Hyperbarics.
Detailed Segmentation:
- Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, By Product Type:
- Monoplace HBOT Devices
- Multiplace HBOT Devices
- Topical HBOT Devices
- Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, By Application:
- Wound Healing
- Decompression Sickness
- Infection
- Gas Embolism
- Others
- Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, By End User:
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Others
- Global Hyperbaric Oxygen Therapy (HBOT) Devices Market, By Region:
- North America
- By Product Type:
- Monoplace HBOT Devices
- Multiplace HBOT Devices
- Topical HBOT Devices
- By Application:
- Wound Healing
- Decompression Sickness
- Infection
- Gas Embolism
- Others
- By End User:
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Others
- By Country:
- U.S.
- Canada
- By Product Type:
- Latin America
- By Product Type:
- By Application:
- By End User:
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- By Application:
- By End User:
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- By Application:
- By End User:
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- By Application:
- By End User:
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- By Application:
- By End User:
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
